HCW Biologics Inc.
HCWB
$7.05
-$0.58-7.60%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 4.67M | 998.20K | 1.16M | 4.08M | 3.60M |
Total Receivables | 582.20K | 651.80K | 655.00K | 903.90K | 1.54M |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 328.20K | 356.20K | 404.90K | 783.40K | 1.04M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 113.50K | 88.10K | 164.60K | 437.30K | 230.90K |
Total Current Assets | 5.70M | 2.09M | 2.39M | 6.21M | 6.40M |
|
|||||
Total Current Assets | 5.70M | 2.09M | 2.39M | 6.21M | 6.40M |
Net Property, Plant & Equipment | 22.91M | 22.83M | 22.81M | 22.59M | 20.45M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 28.50K | 28.50K | 28.50K | 28.50K | 56.50K |
Total Assets | 30.24M | 26.56M | 26.82M | 30.43M | 28.51M |
|
|||||
Total Accounts Payable | 22.33M | 22.67M | 16.88M | 10.49M | 6.17M |
Total Accrued Expenses | 981.90K | 930.70K | 6.22M | 2.92M | 2.43M |
Short-term Debt | 6.31M | 6.34M | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | 126.00K | 124.00K | -- | 147.50K |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 29.63M | 30.06M | 23.22M | 13.41M | 8.75M |
|
|||||
Total Current Liabilities | 29.63M | 30.06M | 23.22M | 13.41M | 8.75M |
Long-Term Debt | 7.38M | 6.46M | 9.90M | 8.27M | 6.30M |
Short-term Debt | 6.31M | 6.34M | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 37.01M | 36.53M | 33.12M | 21.69M | 15.05M |
|
|||||
Common Stock & APIC | 93.79M | 87.21M | 86.98M | 86.74M | 83.99M |
Retained Earnings | -100.56M | -97.18M | -93.28M | -78.00M | -70.53M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -6.77M | -9.97M | -6.30M | 8.74M | 13.46M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -6.77M | -9.97M | -6.30M | 8.74M | 13.46M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -6.77M | -9.97M | -6.30M | 8.74M | 13.46M |
|